GlaxoSmithKline Pharmaceuticals Analyst Meetings Recording Uploaded

GlaxoSmithKline Pharmaceuticals Limited has submitted a regulatory filing to both BSE Limited and The National Stock Exchange of India Limited regarding analyst and institutional investor meetings.

The company has uploaded the video recording of these meetings to its official investor relations website at https://india-pharma.gsk.com/en-in/investors/analyst-meets/.

The filing was digitally signed by Ajay Avinash Nadkarni, Vice President – Administration, Real Estate & Company Secretary of GlaxoSmithKline Pharmaceuticals Limited, on November 5, 2026, at 11:48:49 IST.

The company's Corporate Identification Number (CIN) is L24239MH1924PLC001151.